Oncolytic virus therapy as a powerful promoter of a combined tumor antigen specific Th1 cell and immune checkpoint inhibitor-based cancer immunotherapy
Journal article published in 2022 by
D. Stowbur,
S. Berchtold,
B. F. Schoerg,
J. Beil,
D. Sonanini,
I. Gonzalez-Menendez,
G. Reischl,
W. Ehrlichmann,
R. Beck,
L. Quintanilla-Martinez,
M. Roecken,
B. J. Pichler 
,
U. M. Lauer,
M. Kneilling
,
U. M. Lauer,
M. Kneilling
